SecFilingDex
424B4BIAFCIK 0001712762

bioAffinity Technologies, Inc.

Final prospectus (424B4) filed .

Final prospectus filed under Rule 424(b)(4) that includes the pricing and related information omitted from the registration statement at effectiveness — the common final prospectus for IPOs and public offerings.

Filing facts

Accession number
0001641172-25-008977
Filer
bioAffinity Technologies, Inc.
Ticker
BIAF
CIK
0001712762
Form type
424B4
Form description
Final prospectus
Filed at
May 7, 2025
Filing size
2.2 MB
Last verified
August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.